Literature DB >> 18499582

A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction.

Sekar Kathiresan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18499582     DOI： 10.1056/NEJMc0707445

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  58 in total

1.  The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.

Authors:  Q Feng; W Q Wei; C P Chung; R T Levinson; L Bastarache; J C Denny; C M Stein
Journal:  Pharmacogenomics J       Date:  2016-02-23       Impact factor: 3.550

Review 2.  Consensus statement on the management of dyslipidemia in Indian subjects: A different perspective.

Authors:  Enas A Enas; T S Dharmarajan; Basil Varkey
Journal:  Indian Heart J       Date:  2015-04-30

Review 3.  [LDL-cholesterol and cardiovascular events: the lower the better?]

Authors:  Raimund Weitgasser; Michaela Ratzinger; Margit Hemetsberger; Peter Siostrzonek
Journal:  Wien Med Wochenschr       Date:  2016-10-21

Review 4.  A century of cholesterol and coronaries: from plaques to genes to statins.

Authors:  Joseph L Goldstein; Michael S Brown
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

5.  The transcription factor GATA-2 does not associate with angiographic coronary artery disease in the Ottawa Heart Genomics and Cleveland Clinic GeneBank Studies.

Authors:  Sonny Dandona; Li Chen; Meng Fan; Md Afaque Alam; Olivia Assogba; Melanie Belanger; Kathryn Williams; George A Wells; W H Wilson Tang; Stephen G Ellis; Stanley L Hazen; Ruth McPherson; Robert Roberts; Alexandre F R Stewart
Journal:  Hum Genet       Date:  2009-11-03       Impact factor: 4.132

Review 6.  The rationale for initiating treatment of hypercholesterolemia in young adulthood.

Authors:  Daniel Steinberg
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

7.  Treatment targets in the management of dyslipidemias: which targets in whom?

Authors:  Scott M Grundy
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

Review 8.  Meta-analyses of four eosinophil related gene variants in coronary heart disease.

Authors:  Jiangfang Lian; Yi Huang; R Stephanie Huang; Limin Xu; Yanping Le; Xi Yang; Weifeng Xu; Xiaoyan Huang; Meng Ye; Jianqing Zhou; Shiwei Duan
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

Review 9.  The role of early LDL lowering to prevent the onset of atherosclerotic disease.

Authors:  Brian A Ference; Nitin Mahajan
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

10.  Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.

Authors:  Susan G Lakoski; Fang Xu; Gloria L Vega; Scott M Grundy; Manisha Chandalia; Chun Lam; Robert S Lowe; Michael E Stepanavage; Thomas A Musliner; Jonathan C Cohen; Helen H Hobbs
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.